DB17651InvestigationalGene Therapies
AVR-RD-01 is an investigational ex vivo lentiviral gene therapy developed by AVROBIO Inc. It consists of autologous CD34+ cells that transduced with Lentiviral Vector/alpha-galactosidase A (AGA) encoding for the human... AVR-RD-01 is being investigated for Fabry Disease.
- Code names
- AVR-RD-01
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of AVR-RD-01, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account